Ovarian tissue cryopreservation and transplantation is an experimental tech
nique that has been developed to sustain the reproductive function of women
and children who are faced with sterilizing chemotherapy, radiotherapy, or
radical reproductive surgery. Oocyte cryopreservation, on the other hand,
is less feasible in the context of cancer because there is usually inadequa
te time to complete an ovarian stimulation cycle. The main promise of oocyt
e cryopreservation is that it offers an alternative when embryo freezing is
not possible for technical, regulatory, or religious reasons. Oocyte freez
ing is more suitable for a single woman when the concern is age-related dec
line in fecundity. There have been significant scientific advances in the f
ield of cryopreservation of ovarian tissue and oocytes, especially within t
he past few years. Ovarian function has been reported after the first cases
of ovarian transplantation, and the number of pregnancies from cryopreserv
ed oocytes has grown. Ovarian tissue and oocyte freezing can now be recomme
nded in a carefully selected group of patients, provided that these options
are offered under protocols that are approved by an institutional review b
oard. Curr Opin Obstet Gynecol 13:263-268. (C) 2001 Lippincott Williams & W
ilkins.